Inger Fagerberg Blixter

Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays

Andreas Hillarp, Fariba Baghaei, Inger Fagerberg Blixter et al. · Journal of Thrombosis and Haemostasis · 2010 · 281 citations · Full text

Thrombosis, Coagulation Assays, Hematology +8

Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays

Fariba Baghaei, Inger Fagerberg Blixter, Kerstin M. Gustafsson et al. · Thrombosis and Haemostasis · 2010 · 264 citations · Full text

Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti‐FXa assays

Andreas Hillarp, Kerstin M. Gustafsson, Lars Faxälv et al. · Journal of Thrombosis and Haemostasis · 2014 · 114 citations · Full text

Thrombosis, Anti‐fxa Assays, Medicine +9

Effects of fibrinogen and platelet supplementation on clot formation and platelet aggregation in blood samples from cardiac surgery patients

Caroline Shams Hakimi, Inger Fagerberg Blixter, Emma C. Hansson et al. · Thrombosis Research · 2014 · 22 citations

Thrombosis, Cardiac Surgery Patients, Cardiovascular Disease +13

Effects of the oral, direct factor Xa inhibitor edoxaban on routine coagulation assays, lupus anticoagulant and anti-Xa assays

Andreas Hillarp, Karin Strandberg, Fariba Baghaei et al. · Scandinavian Journal of Clinical and Laboratory Investigation · 2018 · 22 citations · Full text

Immunology, Chromogenic Anti-xa Assays, Lupus Anticoagulant +17